LENZ Therapeutics (LENZ) Earnings Date & Reports

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LENZ is expected to report earnings to rise 97.83% to -91 cents per share on March 25

LENZ Therapeutics LENZ Stock Earnings Reports

Q4'23

Est.

$-0.91

Q4'24

Missed

by $0.36

Q3'23

Est.

$-0.24

Q2'23

Missed

by $5.82

Q1'23

Missed

by $2.61

The last earnings report on March 19 showed earnings per share of -46 cents, missing the estimate of -10 cents. With 75.15K shares outstanding, the current market capitalization sits at 713.13M.

View a ticker or compare two or three

Compare

LENZ